Bioventus Inc
BVS
View Detailed Chart
9.150USD
+0.150+1.67%
Close 03/24, 16:00（ET）Quotes delayed by 15 min
364.52MMarket Cap
26.82P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.67%
5 Days
+1.78%
1 Month
+4.93%
6 Months
+32.80%
Year to Date
+22.98%
1 Year
-5.86%
View Detailed Chart
TradingKey Stock Score of Bioventus Inc
Currency: USD Updated: 2026-03-24Key Insights
Bioventus Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 3 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 14.75.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bioventus Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative-
Bioventus Inc Highlights
StrengthsRisks
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 26.82, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.87M shares, decreasing 0.00% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 19.50K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.49.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
14.750
Target Price
+70.72%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Bioventus Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Bioventus Inc Info
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
Ticker SymbolBVS
CompanyBioventus Inc
CEOClaypoole (Robert E)
Websitehttps://www.bioventus.com/
Related Instruments
+1.02%
-1.79%
+2.55%
-1.28%
-0.75%
+0.05%
-1.23%
-2.00%
+0.38%
+2.12%
-0.68%
+2.08%
+1.68%
-1.43%
-0.40%
-1.06%
+1.95%
+0.13%
+0.10%
-0.20%Popular Symbols
251.640
+0.150 (+0.06%)
175.200
-0.440 (-0.25%)
71660.810
+1597.620 (+2.28%)
301.050
+6.260 (+2.12%)
2181.960
+35.980 (+1.68%)
383.030
+2.180 (+0.57%)
4547.170
+76.670 (+1.71%)
88.049
-0.054 (-0.06%)
1.159
-0.002 (-0.13%)
159.015
+0.320 (+0.20%)
